|Selected research from leading health care experts whose findings have a direct bearing on public policies effecting medical progress. Research is chosen based on its quality and relevance by the Medical Progress Today editorial staff.||
The Future of Drug Safety: Promoting and Protecting the Health of the Public
A full version of the Institute of Medicine report can be found online:
Noting that resources and therefore efforts to monitor medications' riskbenefit profiles taper off after approval, the committee that wrote the report offered a broad set of recommendations to ensure that consideration of safety extends from before product approval through the entire time the product is marketed and used.
|home spotlight commentary research events news about contact links archives|